Oxford GBD (Global Burden of Disease) was established in July 2018 as a partnership between the University of Oxford and the Institute for Health Metrics and Evaluation (IHME) at the University of Washington to conduct strategic research in public health epidemiology.
Our flagship project, GRAM (Global Research on Antimicrobial Resistance), aims to estimate the burden of antimicrobial resistance worldwide using data, health statistics and geospatial maps. The team will apply methodologies used in IHME’s ongoing GBD study to build an evidence base for antimicrobial resistance. We will initially focus on selected antibiotic-resistant microorganisms, and will produce comparable antimicrobial resistance burden estimates for corresponding pathogen-antimicrobial drug combinations from 1990 to the present, in all countries included in IHME’s GBD study. The findings will assist the global research community and policymakers in tailoring interventions at the local level.